1-2 of 2
Florian H. Heidel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis

Open Access
Clinical Trials & Observations
David M. Ross, Florian H. Heidel, Andrew Charles Perkins, Andreas Reiter, Carl Crodel, Caroline Riley, María Teresa Gómez-Casares, Istvan Takacs, Heiko Becker, Thomas Lehmann, Olga Vinogradova, Kate Burbury, Alessandro M. Vannucchi, Vikas Gupta, Marielle Wondergem, Jean-Jacques Kiladjian, Grace Cleary, Angela Zhang, Jagannath Kota, Anirudh Prahallad, Monika Wroclawska, Min Lu, Claire N. Harrison
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4195–4205.
https://doi.org/10.1182/bloodadvances.2025015860
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma

Open Access
Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, Paolo Mazzeo, Rebecca Wurm-Kuczera, Vladan Vucinic, Udo Holtick, Hristo Boyadzhiev, Thomas Melchardt, Alexander Hölscher, Christian Schultze-Florey, Atef Abdelhafez, Giuliano Filippini Velazquez, Anna Ossami Saidy, Vadim Lesan, Ulf Schnetzke, Andrea Kerkhoff, Ulrike Bacher, Susanne Ghandili, Enver Aydilek, Niklas Gebauer, Thomas Weber, Gerald Wulf, Bertram Glass, Lorenz Thurner, Florian H. Heidel, Christoph Schmid, Andreas Viardot, Mathias Hänel, Sascha Dietrich, Thomas Pabst, Francis Ayuk, Bastian von Tresckow, Björn Chapuy, Christiane Pott, Fabian Müller, Georg Lenz
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3955–3966.
https://doi.org/10.1182/bloodadvances.2024015719
Published: 2025
Includes: Supplemental data